<?xml version="1.0" encoding="UTF-8"?>
<p>Moxifloxacin (
 <xref rid="molecules-26-00438-t004" ref-type="table">Table 4</xref>, Compound 
 <bold>18</bold>) and ciprofloxacin (
 <xref rid="molecules-26-00438-t004" ref-type="table">Table 4</xref>, Compound 
 <bold>19</bold>), unsaturated β-amino acid heterocycles, are highly active fluoroquinolones containing a β-amino acid moiety, which are used in the treatment of community-acquired pneumonia caused by 
 <italic>Chlamydia pneumoniae</italic> and chronic prostatitis caused by 
 <italic>Chlamydia trachomatis</italic>, respectively [
 <xref rid="B54-molecules-26-00438" ref-type="bibr">54</xref>,
 <xref rid="B55-molecules-26-00438" ref-type="bibr">55</xref>].
</p>
